Advance Energy Share Discussion Threads

[the chairman elect] 02/9/2022 14:40

BOBBIE8702 Sep '22 - 14:35 - 98 of 98

big talk of a jv between clon and adv on a new project

[dave4545] 02/9/2022 14:39

Fake rumours again smallcappick

Almost 20 years now and you are still at it

[bobbie870] 02/9/2022 14:35

big talk of a jv between clon and adv on a new project

[sweet karolina2] 10/8/2022 14:35

I see the run around ramper, who claims to have me filtered, is still reading all my posts and still too arogant and stupid to learn anything as well as still desperate to stop others learning. If I could be bothered, I would check to see if he ramped any of the 5 now delisted AIM rule 15 shells. As I have done my research, I have seen quite a few of the same names sucked in by the ramps, who have been sucked in here too - those who don't learn from their mistakes are doomed to repeat them.

[the chairman elect] 10/8/2022 08:15

Reference the TROLL thread what a f8ckin' saddo it is!

[sweet karolina2] 09/8/2022 09:45

So who ramped it and who got sucked in by the ramp ahead of that speeding ticket on 14th Apr?

moneymunch12 Apr '20 - 14:04 - 4461 of 6929
0 1 0
15m 40ish seconds into into recording, most definitely worth a listen and very encouraging imho Gla ;-)

Doc Holiday
Easter Weekend ?? #INCE #ORPH #FXPO #NCYT #IHC #RRE #CLG #TILS #MTFB #PFC #PDL #RGM #WSG #LBE


moneymunch12 Apr '20 - 15:58 - 4462 of 6929
0 1 0
Interesting points made by Doc Holiday, in that Motif's main investor Hercules Capital put about $20m into Icaprim's development ,most of which was transferred into share warrants at 0.42p which represents 29% of the company and so they will be keen to recoup their investment at all costs. Icaprim showed strong positive phase 11 trial data for bronchial pneumonia etc, and although they've had no luck in selling the program to date, all of a sudden because of the CV crisis, Icaprim's phase 11 trial data could now be of great interest from those involved in finding treatments for CV patients who are suffering from lung problems, which is hopefully backed up by Lamellar's studies, there's also a great chance that if a Covid related developer wants to gain access to the markets quickly to get their products to market, then the chance of RTO, is very high. Gla holders, all should be revealed this coming week. :-)
moneymunch13 Apr '20 - 07:17 - 4463 of 6929
0 2 0
If Iclaprim is the main compound in Lamellar's LAMELLASOME™ nebulised formulation treatment believed to have inherent attributes that are extremely well suited to be a potential approach to preventing the onset of the serious respiratory symptoms seen in COVID-19 patients, then presumably because Iclaprim has already been cleared in Phase 11 patient trials, then Lamellar's technology and formulation could go straight into CV patient trials. This would be highly significant and make Lamellar the most likely RTO target and transformational for all invested, with the prospect of Lamellar's inhaler technology reaching CV patients immediately , and then potentially scaled up for commercialisation on positive trials, and if this is the case then this would be absolutely huge and maybe the multi-bags of all multi-bags from current rockbottom share price .. Gla holders and fingers firmly crossed!!! ;-)
anslow13 Apr '20 - 10:55 - 4464 of 6929
0 3 0
I’ve noticed John Palmer from tamarack associates who’s responsible for fonding a buyer is no longer advertising iclaprim for sale on his Linkedln profile, it was all there in black and white on Friday, big things happening here in the background
moneymunch13 Apr '20 - 11:26 - 4465 of 6929
0 1 0
Well spotted anslow, a very interesting observation indeed. ;-)
anslow13 Apr '20 - 11:29 - 4466 of 6929
0 1 0
This might of been a dead duck in February pre Covid, this has reborn written all over it
moneymunch13 Apr '20 - 13:04 - 4467 of 6929
0 1 0
Another significant link between MOTIF, Lamellar agreement 1/5/19 and WRAIR agreement 24/10/19,

in the agreement signed between Motif and Lamellar 1/5/19, it states that Motif will conduct an in vivo pre-clinical study evaluating iclaprim in combination with Lamellar's patented LAMELLASOME(TM) technology, which is a nebulised inhaler treatment , and so it's most interesting that in October 2019 ( Pre-Covid-19 ), Motif signed an agreement with WRAIR to conduct pre-clinical testing to evaluate novel combinations with iclaprim to improve safety and efficacy administered by a novel enhanced aerosol technology’....which sounds as if it could be Lemallar's Technology imho, and now given the timing of Lamellar's press release 8/4/20, in the midst of this global CV crisis , suggests that there could be a link to MOTIF as well as WRAIR imho.....Gla ;-)




.....................................

The agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with iclaprim to improve safety and efficacy administered by a novel enhanced aerosol technology’.

RNS Number: 9200Q Motif Bio PLC, 24 October 2019

Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with iclaprim to improve safety and efficacy administered by a novel enhanced aerosol technology.


moneymunch13 Apr '20 - 13:06 - 4468 of 6929
0 0 0
WRAIR

Building on decades of strategic investments into broad capabilities and a product-oriented research infrastructure, the U.S. Army and WRAIR have been able to consistently maintain a posture of readiness and response to the emerging infectious diseases that threaten U.S. and allied forces.

Our researchers are playing a key role in the ongoing COVID-19 response, building upon the Institute’s ability to rapidly respond to outbreaks on an accelerated timeline to develop diagnostics, vaccines and treatments.

............................

Researching Novel Therapies
WRAIR researchers are also conducting research to identify novel therapies for COVID-19. They are pursuing several drug candidates, similar to the ones WRAIR has successfully developed to treat malaria. In addition, they are conducting studies to identify and characterize monoclonal antibodies (mAbs), a type of immunotherapy. WRAIR has proven experience in this area, having successfully isolated mAbs for other viral pathogens.


anslow13 Apr '20 - 22:16 - 4469 of 6929
0 2 0
Well good luck all, I have a feeling we could be in for a great day tomorrow
barnes413 Apr '20 - 23:15 - 4470 of 6929
0 1 0
Blah blah blah

Private ones will have their pants down again tomorrow Zi suspect!!

[sweet karolina2] 09/8/2022 09:15

So what happened next. BiVitriX did an IPO and placing onto AIM. It raised £7.5m Gross. The 20p shareprice shot up initially and hit over 30p but has since dropped back to 20p.

Motif Bio remains as active on Companies House, its annual report is overdue. It is 0p in waiting but could still be several years before shareholders can crystalise the loss to offset against CGT though it does have a shareholder action group:

CAMPBELL4817 Jun '21 - 10:40 - 2 of 17
0 2 0
Dear Fellow Shareholders

Please be advised that there is an active telegram group up and running, with the intention of forming a steering group to proactively engage with Motif IR.

Please kindly join at https//t.me/joinchat/QgkE2kaDcLdjZjk0

All holders interested in salvaging some value are welcome, particularly those with relevant understanding and expertise in dealing with similar experiences.


Motif Telegram Action Group

What a total waste of time!

A few other choice posts:

scottdavid7011 Aug '21 - 16:14 - 2799 of 2806
0 0 0
For anyone defending Gold and Lumsden over the RTO explain these two things:

If the deal was so good and fai for shareholders why didnt they organise a presentation for us to sell the huge advantages it held for us and explain why they were receiving warrants at a 50% better value deal than the very shareholders they got into this sit by failing to get Iclaprim approved, partnered in the 1st place to take some of the risk which Lumsden promised all the way back 2015 and justify why they paid themselves so much including a bonus for Lumsden if the RTO went ahead?

If the deal was so good for shareholders why not explain it? We had total radio silence on the biggest moment of the companies existence which also goes against good Corporate governance.

Also why did Walbrook not once promote the RTO publicly through any medium be it social media or otherwise if the deal was so good after the initial document came out?

For a deal that is supposedly in the shareholders best interests these are strange occurrences (almost like they wanted to keep it on the low down it was even happening given the extent of warrants and shares they were personally getting) wouldn’t you say and hard to understand how they can remain as Director’s of any company with that type of communication with their shareholders over something so significant.

Hedgehog 10011 Aug '21 - 16:17 - 2800 of 2806
0 0 0
Chuffer,

As I've mentioned previously I'm a retail investor who is interested in shares and RTOs.

Which is why I've been running the following thread on ADVFN for over seven years:

"THE REVERSE TAKEOVERS & SHELLS THREAD
Hedgehog 100 11 Mar '14 - 21:09"


I've seen numerous RTOs into shells over the years, and the tax losses never seem to be given any significant value relative to what they could potentially/theoretically save in tax.

Given me one single example of biotech losses in a shell like MTFB that were sold for the sort of sum that you and Scott seem to think they're worth.

Hedgehog 10011 Aug '21 - 17:08 - 2802 of 2806
0 0 0
Also note, Chuffer, that Government Finance Acts in the last decade or so have introduced 'loss-buying' rules intended to counter companies accessing unused corporation tax losses from unconnected parties.

With such anti-avoidance rules, HMRC takes into account all relevant factors in seeking to establish the purpose of the arrangements.

Why don't you think that a complete change of directors could be such a relevant factor, in flagging up the unconnected nature of an acquired company?

[sweet karolina2] 09/8/2022 07:50

I have found another one that failed, but this time at the final hurdle - shareholders rejected it at the GM so the AIM listing was cancelled the next day.

All the news from Motif Bio is here:



MTFB became a Rule 15 shell on 28 Jan 2020 it was divesting itself of assets and had virtualy no cash - the shares crashed to about 0.1p

Shares spiked to 1.5p on rumour so a speeding ticket RNS was issued which calmed things down. "Motif Bio's cash balance was approximately GBP0.25 million as at 14 April 2020 and with outstanding and expected near term obligations the Company currently has sufficient working capital into May 2020.

It did a placing at 0.4p on 5 May 20 raising £650k - at the placing price this gave the company an MCAP of £2.6m "Following the Placing, Motif Bio will have cash of approximately GBP815,000 which will provide the Company with sufficient working capital until February 2021." ADV may have about that much right now, following its recent placing - ADV did not bother to tell us how little cash it has.

Joy of joys the news they had been praying for came on 26 May 21. An RTO of BiVictriX was in the bag and a GM called. The RTO and placing price was 20p, except that was after a 220:1 consolidation so in effect 0.09p

At the RTO and placing price BiVictriX was valued at £5,500,608.20 the placing raised £10.1 million before expenses. The now cashless shell and therefore just the AIM listing, which costs about £500k to get by IPO was valued at £589K. Ie about £89k more than it was worth and the shareholders then rejected the deal and got nothing.

Yes there were some really daft figures paid for shells before COVID, but it is a different world now and, whereas I have yet to find a successful one since COVID this one proves that nobody with half a brain cell pays much more for a dirty cash shell than it is actually worth - £500k plus cash left at time of RTO.

[sweet karolina2] 05/8/2022 17:54

Another issue I knew about but did not mention above:

qackers3 Aug '22 - 18:39 - 1227 of 1228
0 1 1
IG moved my shares from ISA to dealing account

When the shares delist from AIM they are no longer eligible to be held in an ISA. Some providers are quicker to act than others, a relatively short delist and then relist on an eligible market and you might get away with it.

[the chairman elect] 01/8/2022 08:20

Whilst almost everyone was watching the Lionesses that sad old TROLL was busy TROLLING away!

[sweet karolina2] 30/7/2022 18:59

And another delisted from AIM after 12 months from becoming a rule 15 shell:

U.K. SPAC (formerly Mountfield Building Group, became U.K SPAC and AIM rule 15 when it sold its operating divisions) had Net Current Assets of about £2.5m at 30 Sep 21 (had done a £3.156m (gross) placing when it sold its businesses). The RTO is probably still going ahead (cash already in the bank is worth something) and if it does it will relist on the (sub)Standard list (IPO cost about £200k). If it does relist we will be able to see how much of its £4.3m retained losses (used to be marginally profitable before COVID) end up on the balance sheet as a tax credit (it is an England and Wales incorporated company). The directors have genuinely been trying to do the right thing by the pre-exisiting MBG shareholders, but it an uphill battle particularly in current market conditions.

The £3.156m (gross) placing was at 0.1975p. Shares were 0.205p (mid) at suspension but people were paying over 0.3p in the months leading up to suspension. The company has no assets other than its cash which I would guess would be around £2m at relisting on the (sub)Standard list, if it happens. From 2 months ago:



"While the prospectus is still subject to final approval by the FCA eligibility committee, the Directors believe that all substantive issues regarding the text of the prospectus have been addressed."

U.K. SPAC has 1,852,219,137 shares and quite a lot of warrants exercisable at 0.3p. It will be very interesting to see how much gets paid via the RTO and IPO placing price for the existing equity noting that the placing shares represent approximately 84.74% of the Enlarged Issued Share Capital of the Company in issue immediately following Admission.

If anyone fancies a bit of (sub)Standard listed "medical cannabis cultivation business based in a fully secure, custom designed 195,506 square meter facility in Northern Greece. Hellenic plans to grow, manufacture, process and sell medicinal cannabis flowers and related extracted oils initially into the Germany, the United Kingdom,and Greece. The Directors of Hellenic intend that it will become one of, if not the first medical cannabis cultivators to list on the Main Market [(sub)Standard list] of the London Stock Exchange." contact Peterhouse Capital Ltd as the IPO placing may still be open and if you like the price and all the other info that can be provided, go for it. If the IPO fails then you won't lose anything.

Personally I think the cannabis bubble burst ages ago and you would be flogging a nearly dead horse, but DYOR and make your own investing decisions.

[sweet karolina2] 30/7/2022 18:52

An example of another AIM rule 15 cash shell RTO that went wrong and the company was delisted. Last placing was on 20 Jan 21 (shortly after becoming rule 15) at 0.6p. It was suspended at 1.15p (mid) but people were paying over 3p in the months leading up to suspension, excited at the prospect of an RTO.



Note:

"As at 1 July 2021, the Company's cash position (net of current liabilities) was approximately GBP1.9 million." [A hell of a lot more than ADV currently has, even after the placing.]

"Completion of the Proposed Transaction remains subject to certain matters including:

a) commencement and satisfactory completion of all necessary due diligence;
b) completion of a fundraising shortly proposed to be undertaken by Blue Air;
c) exchange and completion of the SPA;
d) approval by Ridgecrest's shareholders, at a general meeting to be convened in due course (the "General Meeting"), of the Proposed Transaction;

e) the raising of an appropriate amount of new equity funds for the enlarged group (the "Placing");

f) the obtaining of a Rule 9 waiver by the UK Takeover Panel in respect of the proposed issue of new shares to Cristian Rada and his brother; and

g) readmission of the enlarged share capital of the Company to trading on AIM."



"Ridgecrest, an AIM Rule 15 cash shell, has terminated negotiations on its proposed reverse takeover of Blue Air*. This is a consequence of Blue Air's inability to raise the pre-RTO funding that was the principal condition of the non-binding heads of agreement between Ridgecrest and Blue Air's vendors referred to in Ridgecrest's announcement of 6 July 2021."



"Ridgecrest Plc (formerly Nakama Group Plc) became an AIM Rule 15 cash shell ("AIM Cash Shell") on 5 January 2021. As a result of not announcing a reverse takeover within 6 months of becoming an AIM Cash Shell, trading in Ridgecrest's shares was suspended on AIM on 6 July 2021, in accordance with the AIM Rules for Companies (the "AIM Rules"). As it has not been possible for Ridgecrest to undertake and conclude a reverse takeover within 12 months of the Company becoming an AIM Cash Shell, admission of Ridgecrest's shares to trading on AIM will be cancelled at 7.00 a.m. on 7 January 2022 ("Cancellation")."

It has since "listed" on JP Jenkins and made a small investment in some no hope business:

jtourer31 Mar '22 - 11:45 - 1589 of 1604
0 2 0
I wouldnt have known about this if you hadnt posted, as I have never previously heard of JP Jenkins. Nor is it on their web-site. So I thank you but are just more annoyed with this company.
starpukka31 Mar '22 - 12:09 - 1590 of 1604
0 0 0
Does this at all increase the chances of us getting some of our money back ?
Orange131 Mar '22 - 12:31 - 1591 of 1604
0 0 0
Not if this company information is anything to go by:


jtourer22 Apr '22 - 10:48 - 1592 of 1604
0 0 0
Has anyone tried trading any of these shares ?
Festario22 Apr '22 - 11:13 - 1593 of 1604
0 0 0
It’s basically impossible
jtourer22 Apr '22 - 11:34 - 1594 of 1604
0 0 0
So they effectively have run off with our cash then !
Festario22 Apr '22 - 11:37 - 1595 of 1604
0 0 0
Pretty much.....
Although I hear murmurings of possibilities in the future.
But it’s all very amateurish.
jtourer31 May '22 - 16:55 - 1596 of 1604
0 1 0
From what I can see here the Directors of this company have done just enough to both stop the possibility of any fraud inquiries and also to stop holders recouping any of their cash. They seem to know what they are doing in this respect.

Sounds a lot like an uber dog with fleas, unfortunately for them ADV is MY favourite uber dog with fleas and I don't try to cover any others.

[sweet karolina2] 30/7/2022 18:15

To explain how tax credit against past losses work.

Firstly it is quite complex with a lot of rules about including them on the balance sheet and if you really want the right answer in a specific circumstance then you need an accountant who specialises in such matters.

Since 2017, if an England and Wales incorporated operating company merged with another England and Wales incorporated operating company, then the tax losses could be used to offset against future tax payments. To illustrate: Company A is still operating and has made losses since 2017 of £10m, Company B, which makes a taxable profit, merges with company A through an RTO (eg Company A is smaller but listed and by Company B merging the overall company is listed and hopefully still profitable).

Corporation tax in England and Wales is currently 19%, going up to 23% in Apr 23. Using the 19% figure, potentially the new company can have up to £1.9m on its balance sheet as tax credit - it is not money to be paid by HRMC, but money that does not have to be paid to HRMC on future profits made post merger. How much to pay in the RTO for that tax credit is another subject and would form part of the due diligence and negotiation process.

I am 99.9% certain that when Company A is no longer operating and is just a dirty cash shell, the historic losses cannot be used by the new company. Very happy to be PROVED wrong as I will have learned something I did not know and that is worth more than any embarassment at being PROVED wrong about the 0.1%.

If you do the same calculation for what tax credit could be on the balance sheet for an IoM incorporated Company A where the corporation tax rate is 0%, then the answer to what could go on the balance sheet to offset against future tax is £0. I don't think it is necessary to debate what might be paid in the RTO for that £0.

[sweet karolina2] 30/7/2022 17:11

ADV is an Isle of Man incorporated company - corporation tax rate 0%. All the shareholders' money sent to money heaven over the years (about £50m) is worth nothing in tax credit.

PPG retained losses are only £10m so in that regard ADV is indeed in a different league for sending shareholders' money to money heaven. Although the rules on tax credit in England and Wales changed in 2017, I have found no evidence to support the argument that they can now be used by a company RTOing into a dirty shell - they certainly could not be prior to 2017.





I would welcome anyone who can provide evidence posting it. I can do no more to prove a negative those who think I am wrong please prove it.

Not that this is relevant to ADV as it has no tax credit anyway as already stated - that is a FACT.

[daar] 30/7/2022 06:44

Ppg didn't have an tax losses (4m)!! Adv is in a different league.

[sweet karolina2] 29/7/2022 13:53

To give a real world example of what I am talking about regarding RTOs:

PPG became a dirty cashless shell under AIM rule 15. It suspended on announcement of a Heads of Terms for Ben's Creek to RTO in, but that was about when it was due to suspend under the 6 month rule anyway. The DD started and something went wrong - we are not sure what and will never know, but the Nomad resigned and PPG lost its AIM listing. Ben's Creek backed out and, because the DD is the same, did its own IPO quickly and easily raising all the money it wanted to. Ticker is BEN if you want to see how it has done since. whatever your views on that, it has done much better not having the baggage that would have come from an RTO into PPG.

PPG still claims to be pursuing a relisting on the (sub)Standard list with an RTO in waiting - nothing has happened though for about a year and 0p is almost certain.

Could the same happen to ADV - yes. ADV is an uber dog with fleas, but PPG was even worse.

[sweet karolina2] 28/7/2022 19:57

Run around ramper has got it WRONG again because he is just so arrogant and opinionated and knows sweet FA about the process.


The Chairman Elect28 Jul '22 - 09:05 - 2712 of 2712
0 0 0
On the assumption that everyone who frequents these BBs is over 18 then any of the risks associated with shells and RTOs aka @ LSE:ADV are taken as read [He has no idea what they are because he knows Sweet FA but he thinks he is clever - the most dangerous kind of fool]!

Of course LSE:ADV is high risk [RIGHT] but also extremely high reward [badly WRONG] - you pays yer money yer and you take yer chances! [only if you are a total mug punter]

Good luck to all REAL shareholders @ LSE:ADV


It costs about £500k to get an AIM listing (about £200k for Standard list) ADV just raised enough to get through the readmission process, which will take at least 3 months from Heads of Terms, when the shares will be suspended.

What does ADV have that adds any value over and above its listing? - any cash not swallowed up by the directors and that is it. It also comes with a lot of baggage.

Why would a company want an AIM listing? - the answer is very very simple - to be able to raise money by issuing shares. So whatever RTOs in will do a placing at the RTO price to raise whatever it needs.

How is the RTO company valued? - that is what most of the due diligence and other stuff ADV has said it has raised the money to do is about. The RTO company will also do DD on ADV to make sure there are no nasty surprises lurking - there are examples where skeletons have come out of the closet after the RTO and screwed the RTO company.

So how much to pay for an RTO into ADV as opposed to an IPO? - the timescales are about the same and the costs are about the same. Pretty simple £500k plus any cash left when you get there - any more than that and you are paying more than it is worth (not a good idea to do that when you want to convince new investors to invest in you). If the RTO company pays much more, the RTO company is screwing its own existing shareholders and is less likely to be able to raise the money in the placing. The RTO company does not have to do an RTO at all - it can IPO or it could use any shell if it still wants to RTO. ADV HAS to do an RTO or it delists and goes to 0p. The RTO company therefore holds all the aces and a gun to ADV BoD head.

An example to make the maths easy. The RTO Company is worth £10m and wants to raise £9m before placing fees (normally 5%). It agrees to value ADV at £1m. With 1.5Bn shares already in issue that is an RTO price of 0.066p and that will also be the placing price, but if the Brokers can't get the placing away at that price then it will come down or the whole thing falls apart has happened plenty of times before. In this example there are 30Bn shares at the end and will probably do a 50 or 100 to 1 consolidation. Assuming 100 to 1, shares start trading agin a 6.6p and this might be where run around ramper thinks money has been made but he would be WRONG yet again.

So where is the REAL reward for REAL ADV shareholders? There isn't one.

Ahh but what if the share price shoots up after the RTO. Entirely possible but not inevitable as it depends on what is RTOed in and whether the market likes it or not. If you like what is being RTOed in and want some then, when you know what it is and decide you like it, just sign up with the broker to take part and get all the readmission documentation CPRs etc and DYOR before you decide to part with your cash at 0.066p. Far less risk that way and far greater reward too.

So the run around ramper who knows sweet FA is not really bringing anyone good luck but is putting a curse on anyone daft enough to blindly buy in on his mindless run around ramping.

[the chairman elect] 28/7/2022 09:05

On the assumption that everyone who frequents these BBs is over 18 then any of the risks associated with shells and RTOs aka @ LSE:ADV are taken as read!

Of course LSE:ADV is high risk but also extremely high reward - you pays yer money yer and you take yer chances!

Good luck to all REAL shareholders @ LSE:ADV

[sweet karolina2] 28/7/2022 00:11

Beware of the run around ramper:

The Chairman Elect28 May '22 - 07:30 - 2658 of 2711
0 2 1
More rubbish above and previous posts. RTO is the 2nd option after injection of new oil & gas assets. [WRONG]

AIM is it as standard list now requires a minimum MKT CAP of £30M [WRONG - £700k he does not know the difference between the Standard list and the High Growth Segment and does not know the difference between a speculative punt and a mug punt.]

Tax losses can be c/f against businesses in the same sector so new oil & gas assets would most likely work. [WRONG it's an IOM Company that does not pay tax]

You need to be more fact based and balanced in your posting plus less opinionated.... [WRONG the run around ramper just copy pastes bits of RNSs round lots of boards and knows nothing about how any of this really works]

This little uber dog with fleas has never proved me wrong and neither has the run around ramper.

[the chairman elect] 27/7/2022 21:05

Absolutely daar but if I were you I would not waste any time putting the main TROLL in it's place as it knows jack sh8t about anything especially the workings of the City!

[sweet karolina2] 27/7/2022 17:42

Looks like the run around ramper TCE has been running around with his head on fire over this and sucked in a few naive punters. This little uber dog has never proved me wrong. TCE got it badly wrong before and will again.

Just remember you now need to multiply any RTO and placing price by 1.5 Bn to see what would be paid for this dirty very little cash shell. Also remember a company can IPO for its own AIM listing, without all the baggage that comes with a shell (like 1.5 Bn shares already in issue), for about £500k.

Ask yourself why would a cash generative oil producing company want an AIM listing at all? (sub)Standard list is much cheaper and can be used as a stepping stone to Premium list if they don't already qualify.

[daar] 27/7/2022 16:37

It's formality to add in the rns that "there is no guarantee that an rto will happen".. No company can say that they are sure it will happen..